Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000252352 is a small nucleolar RNA gene, not a protein-coding gene, and is not classified as a typical therapeutic target such as receptor, enzyme, or transporter[3]. Small nucleolar RNAs are a class of non-coding RNAs that primarily guide chemical modifications (e.g., methylation, pseudouridylation) of other RNAs, especially ribosomal RNA, through base pairing-dependent specificity. No established disease role, drug interaction, or biomarker status exists for ENSG00000252352 in the current literature[3][5]. If you seek information on a protein-coding therapeutic target, ENSG00000252352 is not suitable—it is a snoRNA gene rather than a receptor or drug target. This entry is thus likely incorrect for classical drug discovery and pharmacology purposes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA, ENSG00000252352 (ENSG00000252352).